|
USA-MD-SALISBURY Azienda Directories
|
Azienda News:
- Update on Antiseizure Medications 2025 - PubMed
Objective: This article is an update from the article on antiseizure medication therapy published in the three previous Continuum issues on epilepsy and is intended to cover the vast majority of agents currently available to neurologists in the management of patients with epilepsy This article addresses antiseizure medications individually
- Update on Antiseizure Medications 2025 : CONTINUUM: Lifelong . . .
addresses antiseizure medications individually, focusing on key pharmacokinetic characteristics, indications, and modes of use LATEST DEVELOPMENTS Since the most recent version of this article was published, one new antiseizure medication, ganaxolone, has been approved by the US Food and Drug Administration (FDA), and the indications of some approved medications were expanded Older
- New Epilepsy Treatments 2025 - Everyone. org
Dietary interventions, particularly the ketogenic diet, have been utilized as effective treatment options for certain types of epilepsy, especially in children with drug-resistant seizures The ketogenic diet is a high-fat, low-carbohydrate, and adequate-protein diet that induces a metabolic state known as ketosis
- Epilepsy Pipeline Tracker - Epilepsy Foundation
The Epilepsy Pipeline Tracker is a community-supported resource to share the progress of epilepsy therapies Explore updates on new drugs, supplements, devices, and tools By sharing information, we can speed up new therapies for people living with epilepsy and seizures
- New epilepsy drugs: what is in the pipeline? - Labiotech. eu
According to the World Health Organization (WHO), around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally Although treatments are already available for the disease – which include narrow-spectrum anti-epileptic drugs (AEDs) to treat specific types of seizures, and broad-spectrum AEDs to treat generalized seizures – it is
- Novel antiseizure medications in the development pipeline . . .
In the past decade, we have observed a paradigm shift in the discovery of novel antiseizure medications (ASMs), which is a consequence of significant progress in epilepsy genetics, the availability of novel disease models, drug-screening technologies, the discovery of new mechanisms of action, expanding existing drugs into new populations, or new routes of delivery This resulted in a very
- New drug offers relief for treatment-resistant epilepsy patients
In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows Unlike
- Drug treatment improves epilepsy-like disease in lab . . .
Overview of study design and basic NGN2 culture characterization Credit: Communications Biology (2025) DOI: 10 1038 s42003-025-08194-6
- Epilepsy treatment: New drug shows reduced seizures
Researchers say a new medication, XEN1101, performed well in a phase 2B clinical trial in reducing seizures in people with treatment resistant epilepsy
- Current Epilepsy Treatment and New Medications - WebMD
Treatments for epilepsy have come a long way in the last several years with new epilepsy medications proving more and more effective Researchers have learned more about the causes of epilepsy and
|
|